Back
Cassava Sciences, Inc. 10K Form
Sell
41
SAVA
Cassava Sciences, Inc.
Last Price:
$3.33
Seasonality Move:
28.64%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-12 | 10Q | SAVA/Cassava Sciences, Inc. Quarterly |
| 2020-05-06 | 10Q | SAVA/Cassava Sciences, Inc. Quarterly |
| 2020-03-26 | 10K | SAVA/Cassava Sciences, Inc. Annual |
| 2019-10-29 | 10Q | SAVA/Cassava Sciences, Inc. Quarterly |
| 2019-08-12 | 10Q | SAVA/Cassava Sciences, Inc. Quarterly |
| 2019-05-02 | 10Q | SAVA/Cassava Sciences, Inc. Quarterly |
Receive SAVA News And Ratings
See the #1 stock for the next 7 days that we like better than SAVA
SAVA Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-6.3M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.69 |
| Price / Book: | 1.97 |
Profitability
| EPS (TTM): | -2.19790 |
|---|---|
| Net Income (TTM): | $-106M |
| Gross Margin: | $-1.1M |
| Return on Equity: | -86.98% |
| Return on Assets: | -67.34% |
Cassava Sciences, Inc. Earnings Forecast
Key Cassava Sciences, Inc. Financial Ratios
-
Per Share Earnings over the last 26 years have been positive in 11 years.
Cassava Sciences, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | SAVA |
| CUSIP: | 14817C |
| Website: | cassavasciences.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 2.27 |
| Quick Ratio: | 2.21 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
SAVA Technical Analysis vs Fundamental Analysis
Sell
41
Cassava Sciences, Inc. (SAVA)
is a Sell
Is Cassava Sciences, Inc. a Buy or a Sell?
-
Cassava Sciences, Inc. stock is rated a SellThe current Cassava Sciences, Inc. [SAVA] share price is $3.32. The Score for SAVA is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.